New research from Italy found that Laparoscopic Hyperthermic Intraperitoneal Chemotherapy, or HIPEC, may be successful in treating patients with peritoneal mesothelioma. The results showed that a 49-year old female suffering from peritoneal mesothelioma felt significant comfort after undergoing HIPEC treatments. Researchers discovered that ascites, which is a swollen, painful concentration of fluid within the abdominal cavity, were lessened after the female underwent HIPEC. Actually , the ascites had not appeared back when researchers followed up with the patient about six months after the study.

HIPEC treatments are an “option” for peritoneal mesothelioma patients according to a medical spokesperson from the University of Perugia in Italy. There will be additional research to be done to determine a standard dosage for HIPEC treatments.

An article from the Journal of Gastrointestinal Surgery reported that a combination of cytoreductive surgery (surgery to reduce cancerous cells) and HIPEC is “a promising treatment for patients with peritoneal malignancies.” The article also said that HIPEC is “safe” and “feasible” when it follows cytoreductive surgery, and that the results of the related research are “encouraging”.

Source: Possible New Treatment For Malignant Peritoneal Mesothelioma Patients

Share This